What is the projected market valuation for the China blood grouping-reagents market in 2035?

The projected market valuation for the China blood grouping-reagents market in 2035 is $0.232 Million. Read More

What was the overall market valuation in 2024?

The overall market valuation in 2024 was $0.104 Million. Read More

What is the expected CAGR for the China blood grouping-reagents market during the forecast period 2025 - 2035?

The expected CAGR for the China blood grouping-reagents market during the forecast period 2025 - 2035 is 7.51%. Read More

Which companies are considered key players in the China blood grouping-reagents market?

Key players in the market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Grifols, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, and Becton Dickinson and Company. Read More

What are the main product segments in the China blood grouping-reagents market?

The main product segments include Consumables and Instruments, with valuations of $0.065 - $0.145 Million and $0.039 - $0.087 Million, respectively. Read More

What are the primary test types in the China blood grouping-reagents market?

Primary test types include Blood Group and Phenotype, Antibody Screening, Cross-matching Tests, and others, with valuations from $0.013 - $0.055 Million. Read More

Who are the main end users of blood grouping reagents in China?

Main end users include Hospitals, Blood Banks, and Clinical Laboratories, with valuations of $0.042 - $0.096 Million, $0.032 - $0.072 Million, and $0.03 - $0.064 Million, respectively. Read More

How does the market for blood grouping reagents in China compare to other regions?

While specific comparisons to other regions are not provided, the growth potential in China appears robust, with a projected CAGR of 7.51%. Read More

What factors may influence the growth of the blood grouping-reagents market in China?

Factors influencing growth may include advancements in technology, increasing demand for blood testing, and the presence of key players like Abbott Laboratories and Roche Diagnostics. Read More

China Blood Grouping Reagents Market

Q: What techniques are utilized in the China blood grouping-reagents market?

Techniques utilized include PCR-based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, and Serology, with valuations ranging from $0.015 - $0.07 Million. Read More

ID: MRFR/HC/51496-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

China Blood Grouping Reagents Market Research Report: Size, Share, Trend Analysis By Product (Consumables, Instruments), By Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), By Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, Antigen Typing) and By End Users (Hospitals, Blood Banks, Clinical Laboratories) - Growth Outlook & Industry Forecast 2025 To 2035

China Blood Grouping Reagents Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Product (USD Million)
  1. 4.1.1 Consumables
  2. 4.1.2 Instruments
2. 4.2 Life Sciences, BY Technique (USD Million)
  1. 4.2.1 PCR-based and Microarray Technique
  2. 4.2.2 Assay-Based Techniques
  3. 4.2.3 Massively Parallel Sequencing Techniques
  4. 4.2.4 Serology
  5. 4.2.5 Other Techniques
3. 4.3 Life Sciences, BY Test Type (USD Million)
  1. 4.3.1 Blood Group and Phenotype
  2. 4.3.2 Antibody Screening
  3. 4.3.3 Cross-matching Tests
  4. 4.3.4 Antibody Identification
  5. 4.3.5 Coombs Tests
  6. 4.3.6 Antigen Typing
4. 4.4 Life Sciences, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Blood Banks
  3. 4.4.3 Clinical Laboratories
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche Diagnostics (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Siemens Healthineers (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Grifols (ES)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Ortho Clinical Diagnostics (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Bio-Rad Laboratories (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Thermo Fisher Scientific (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Becton Dickinson and Company (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 CHINA MARKET ANALYSIS BY PRODUCT
3. 6.3 CHINA MARKET ANALYSIS BY TECHNIQUE
4. 6.4 CHINA MARKET ANALYSIS BY TEST TYPE
5. 6.5 CHINA MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY PRODUCT, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY PRODUCT, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY TECHNIQUE, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY TECHNIQUE, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY TEST TYPE, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY TEST TYPE, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNIQUE, 2025-2035 (USD Million)
  3. 7.2.3 BY TEST TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

China Life Sciences Market Segmentation

Life Sciences By Product (USD Million, 2025-2035)

Consumables
Instruments

Life Sciences By Technique (USD Million, 2025-2035)

PCR-based and Microarray Technique
Assay-Based Techniques
Massively Parallel Sequencing Techniques
Serology
Other Techniques

Life Sciences By Test Type (USD Million, 2025-2035)

Blood Group and Phenotype
Antibody Screening
Cross-matching Tests
Antibody Identification
Coombs Tests
Antigen Typing

Life Sciences By End User (USD Million, 2025-2035)

Hospitals
Blood Banks
Clinical Laboratories

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”